University of Kentucky, Department of Psychology, Lexington, KY, USA.
University of Kentucky, Markey Cancer Center, Lexington, KY, USA.
Nicotine Tob Res. 2022 Oct 26;24(11):1781-1788. doi: 10.1093/ntr/ntac114.
This intensive longitudinal study describes key events in the process of smoking cessation after a new head and neck cancer (HNC) diagnosis. Prior longitudinal studies show some cancer patients quit, while others continue to smoke, but details about the pattern in which these discrete outcomes arise are scarce. This study is meant to help rectify this gap in the literature.
Participants were 42 HNC patients who reported current smoking at enrollment. Participants were recruited from an outpatient oncology clinic and completed a baseline questionnaire prior to begin a 30-day daily assessment.
Few participants (9.52%) achieved 30-day continuous abstinence from smoking. On average, participants reported 9.64 ± 11.93 total days of abstinence. Nearly, all (94.44%, n = 34) participants made at least one quit attempt, with an average of 16.94 ± 11.30 quit attempt days. Fewer participants were able to achieve a 24-hour quit attempt (52.78%, n = 19), with a corresponding average of 5.50 ± 8.69 24-hour days. The median time to first 24-hour quit attempt was 13 days after enrollment. Based on smoking behavioral patterns, participants were categorized into five groups, the most common being "persistent attempters," which involved unsuccessful quit attempts throughout the study. Only 45% of participants (n = 19) used evidence-based treatment, the most common being cessation medication.
This intensive longitudinal study found that cancer diagnosis can spur a lot of efforts to quit smoking. Unfortunately, this study suggests that many quit attempts are short lived, possibly a result of an absence or insufficient use of evidence-based treatments.
For adults who are current smokers at the time of cancer diagnosis, there is a high likelihood of persistent cigarette smoking and use of other tobacco products in the weeks and months after a cancer diagnosis. Furthermore, this study shows that while a lot of quit attempts may occur, few are successful, which may be partly attributable to the low use of evidence-based tobacco treatment. Future research with cancer patients should aim to identify predictors of quit attempts and abstinence as well as treatment utilization.
本强化纵向研究描述了新发头颈部癌症（HNC）诊断后戒烟过程中的关键事件。先前的纵向研究表明，一些癌症患者戒烟，而另一些则继续吸烟，但关于这些离散结果出现模式的详细信息很少。本研究旨在帮助纠正这一文献空白。
参与者为 42 名在入组时报告当前吸烟的 HNC 患者。参与者从门诊肿瘤诊所招募，并在开始为期 30 天的每日评估前完成基线问卷。
很少有参与者（9.52%）实现了 30 天的连续戒烟。平均而言，参与者报告了 9.64 ± 11.93 天的总戒烟天数。几乎所有（94.44%，n=34）参与者都至少尝试了一次戒烟，平均尝试天数为 16.94 ± 11.30 天。能够实现 24 小时戒烟尝试的参与者较少（52.78%，n=19），相应的平均 24 小时天数为 5.50 ± 8.69 天。首次 24 小时戒烟尝试的中位时间为入组后 13 天。根据吸烟行为模式，参与者分为五组，最常见的是“持续尝试者”，即在整个研究过程中均为不成功的戒烟尝试。只有 45%的参与者（n=19）使用了基于证据的治疗方法，最常见的是戒烟药物。
本强化纵向研究发现，癌症诊断可以激发大量戒烟努力。不幸的是，本研究表明，许多戒烟尝试持续时间很短，可能是由于缺乏或未充分使用基于证据的治疗方法。
对于在癌症诊断时为当前吸烟者的成年人，在癌症诊断后的数周和数月内，很可能持续吸烟并使用其他烟草制品。此外，本研究表明，尽管可能会进行大量戒烟尝试，但很少有成功的，这可能部分归因于基于证据的烟草治疗使用率低。未来的癌症患者研究应旨在确定戒烟尝试和戒烟以及治疗使用率的预测因素。
